Suppr超能文献

机器人辅助胰十二指肠切除术与开放性胰十二指肠切除术治疗胰腺癌的长期肿瘤学结局

Long-term oncologic outcomes of robot-assisted pancreaticoduodenectomy versus open pancreaticoduodenectomy for pancreatic cancer.

作者信息

Seo Younsoo, Jung Hye-Sol, Han Youngmin, Lee Inhyuck, Choi Go-Won, Chae Yoon Soo, Yun Won-Gun, Cho Young Jae, Kwon Wooil, Park Joon Seong, Jang Jin-Young

机构信息

Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, 28 Yongon-Dong, Jongno-Gu, Seoul, 110-744, Republic of Korea.

出版信息

Surg Endosc. 2025 Jul 9. doi: 10.1007/s00464-025-11833-y.

Abstract

BACKGROUND

Robot-assisted pancreaticoduodenectomy (RPD) has been gaining attention for its potential benefits in short-term surgical outcomes compared with open pancreaticoduodenectomy (OPD) in pancreatic cancer. However, the evidence of its long-term oncological efficacy is limited.

METHODS

This retrospective study compared the long-term outcomes of RPD and OPD in patients with pancreatic cancer at Seoul National University Hospital between January 2015 and October 2023. Patients with stage III or IV disease and those who underwent open surgery were excluded. Propensity score matching (PSM) at a 1:2 ratio was performed based on sex, age, the American Society of Anesthesiologists (ASA) class, and initial resectability. The primary outcomes were overall survival (OS) and disease-free survival (DFS), and the secondary outcomes were postoperative recovery and complication rates.

RESULTS

In total, 522 patients (82 RPD and 440 OPD) were reviewed, and 82 RPD and 164 matched OPD patients were analyzed after PSM. The mean age was 64.8 years in the RPD and 65.2 years in the matched OPD group; there were 51.2% male patients in the RPD and 52.4% in the OPD groups. After PSM, patients with RPDs showed better OS and DFS (5-year OS 58.2% vs. 32.3%, P = 0.001; 5-year DFS: 44.6% vs. 24.7%, P = 0.005). The R0 resection rates and harvested lymph node (LN) number were also comparable (RPD versus OPD: R0 resection rate 92.7% versus 90.9%, P = 0.809; harvested LNs 20.0 ± 7.3 versus 23.1 ± 11.5, P = 0.090). Additionally, patients with RPD had a shorter postoperative recovery time and relatively higher adjuvant therapy completion rate, although the difference was only marginally significant (91.6% vs. 75.4%, P = 0.062).

CONCLUSION

RPD is a feasible alternative to OPD, with potential advantages of early recovery without compromising long-term outcomes after PSM. However, further prospective studies are required to confirm these findings.

摘要

背景

与开放性胰十二指肠切除术(OPD)相比,机器人辅助胰十二指肠切除术(RPD)因其在胰腺癌短期手术结果方面的潜在优势而受到关注。然而,其长期肿瘤学疗效的证据有限。

方法

这项回顾性研究比较了2015年1月至2023年10月在首尔国立大学医院接受治疗的胰腺癌患者RPD和OPD的长期结果。排除III期或IV期疾病患者以及接受开放手术的患者。根据性别、年龄、美国麻醉医师协会(ASA)分级和初始可切除性,以1:2的比例进行倾向评分匹配(PSM)。主要结局为总生存期(OS)和无病生存期(DFS),次要结局为术后恢复情况和并发症发生率。

结果

总共对522例患者(82例RPD和440例OPD)进行了评估,PSM后分析了82例RPD患者和164例匹配的OPD患者。RPD组的平均年龄为64.8岁,匹配的OPD组为65.2岁;RPD组男性患者占51.2%,OPD组为52.4%。PSM后,RPD患者的OS和DFS更佳(5年OS:58.2%对32.3%,P = 0.001;5年DFS:44.6%对24.7%,P = 0.005)。R0切除率和获取的淋巴结(LN)数量也相当(RPD与OPD:R0切除率92.7%对90.9%,P = 0.809;获取的LN数量20.0 ± 7.3对23.1 ± 11.5,P = 0.090)。此外,RPD患者的术后恢复时间较短,辅助治疗完成率相对较高,尽管差异仅具有边缘显著性(91.6%对75.4%,P = 0.062)。

结论

RPD是OPD的一种可行替代方案,在PSM后具有早期恢复的潜在优势,且不影响长期结局。然而,需要进一步的前瞻性研究来证实这些发现。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验